Medi-Tech Insights Get in touch

Global Vaccines Market Size, Share, Growth & Trends Report Segmented by Vaccine Type (Recombinant, Conjugate, Inactivated, mRNA), Route of Administration (Oral, Parenteral, Nasal), Disease Type (Viral, Bacterial, Cancer), Age and Distribution Channel, & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Vaccines Market
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising prevalence of infectious diseases
          • Increased government funding and immunization programs
          • Advancements in vaccine technologies
          • Growing public awareness about vaccine benefits
          • Rise in pharmaceutical R&D investment
        • Restraints
          • High costs associated with vaccine R&D
          • Stringent regulatory approval processes
          • Limited healthcare infrastructure in certain regions
        • Opportunities
          • Growth in adult vaccination markets
          • Expansion of contract manufacturing
          • Increasing partnerships between governments and biotech firms
          • Expanding vaccine access in emerging markets
        • Key Market Trends
          • mRNA vaccine technology expansion beyond COVID-19
          • Growth in digital health solutions for vaccine tracking and management
        • Unmet i>Industry Speaks
  • Global Vaccines Market Size & Forecast (2024-2031), By Vaccine Type, USD Billion
    • Introduction
    • Recombinant Vaccines
    • Conjugate Vaccines
    • Inactivated
    • Live Attenuated
    • Viral Vector Vaccines
    • mRNA Vaccines
    • Others
  • Global Vaccines Market Size & Forecast (2024-2031), By Route of Administration, USD Billion
    • Introduction
    • Oral
    • Parenteral
    • Nasal
  • Global Vaccines Market Size & Forecast (2024-2031), By Disease Type, USD Billion
    • Introduction
    • Viral Diseases
      • Hepatitis
      • Influenza
      • HPV
      • MMR
      • Rotavirus
      • Herpes Zoster
      • Covid-19
      • Others
    • Bacterial Vaccines
      • Meningococcal Diseases
      • Pneumococcal diseases
      • DPT
      • Others
    • Cancer Vaccines
    • Allergy Vaccines
    • Others
    1. Global Vaccines Market Size & Forecast (2024-2031), By Age, USD Billion
      • Introduction
      • Paediatric
      • Adult
    2. Global Vaccines Market Size & Forecast (2024-2031), By Distribution Channel, USD Billion
      • Introduction
      • Hospitals
      • Retail Pharmacies
      • Government Suppliers
      • Others
    3. Global Vaccines Market Size & Forecast (2024-2031), By Region, USD Billion
      • Introduction
      • North America Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion
        • US
          • Market Size & Forecast, By Vaccine Type (USD Billion)
          • Market Size & Forecast, By Route of Administration (USD Billion)
          • Market Size & Forecast, By Disease Type (USD Billion)
          • Market Size & Forecast, By Age (USD Billion)
          • Market Size & Forecast, By Distribution Channel (USD Billion)
        • Canada
          • Market Size & Forecast, By Vaccine Type (USD Billion)
          • Market Size & Forecast, By Route of Administration (USD Billion)
          • Market Size & Forecast, By Disease Type (USD Billion)
          • Market Size & Forecast, By Age (USD Billion)t i>
          • Europe Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion
            • UK
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • Germany
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • France
              • Market Size & Forecast, By Vaccine Tt Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • Italy
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • Spain
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By D Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
          • Asia Pacific (APAC) Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion
            • China
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • Japan
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Mease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • India
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distribution Channel (USD Billion)
            • Rest of Asia Pacific
              • Market Size & Forecast, By Vaccine Type (USD Billion)
              • Market Size & Forecast, By Route of Administration (USD Billion)
              • Market Size & Forecast, By Disease Type (USD Billion)
              • Market Size & Forecast, By Age (USD Billion)
              • Market Size & Forecast, By Distri (2024-2031), USD Billion
                • Market Size & Forecast, By Vaccine Type (USD Billion)
                • Market Size & Forecast, By Route of Administration (USD Billion)
                • Market Size & Forecast, By Disease Type (USD Billion)
                • Market Size & Forecast, By Age (USD Billion)
                • Market Size & Forecast, By Distribution Channel (USD Billion)
              • Middle East & Africa (MEA) Vaccines Market Size & Forecast (2024-2031), USD Billion
                • Market Size & Forecast, By Vaccine Type (USD Billion)
                • Market Size & Forecast, By Route of Administration (USD Billion)
                • Market Size & Forecast, By Disease Type (USD Billion)
                • Market Size & Forecast, By Age (USD Billion)
                • Market Size & Forecast, By Distribution Channel (USD Billion)<"list-style-type: none">
                  • Key Players and their Competitive Positioning
                    • Key Player Comparison
                    • Segment-wise Player Mapping
                    • Market Share Analysis (2025)
                    • Company Categorization Matrix
                      • Dominants/Leaders
                      • New Entrants
                      • Emerging Players
                      • Innovative Players
                    • Key Strategies Assessment, By Player (2023-2026)
                      • New Product Launch
                      • Partnerships, Agreements, & Collaborations
                      • Mergers & Acquisitions
                      • Geographic Expansion
                1. Company Profiles*

                (Business Overview, Financial Performance**, Products Offered, Recent Developments)

                • Merck & Co. Inc.
                • Pfizer Inc.
                • Moderna Inc.
                • CSL Seqirus
                • Sanofi SA
                • GSK Plc.
                • Sinovac Biotech Ltd.
                • BioNTech SE
                • AstraZeneca
                • Serum Institute of India Pvt. Ltd.
                • Emergent BioSolutions Inc.
                • Other Prominent Players

                Note: *Indicative list

                **For listed companies

    Related Reports

    View All Research Reports